California Senate Resolution 122 (SR122) designates November 2026 as Pancreatic Cancer Awareness Month in California. The resolution highlights the severity of pancreatic cancer, noting that in 2026, an estimated 67,530 Americans will be diagnosed with the disease, and 52,740 will die from it. It emphasizes the need for increased awareness and support for those affected by pancreatic cancer. ([legiscan.com](https://legiscan.com/CA/text/SR122/id/3455205?utm_source=openai))
The passage of SR122 is expected to raise awareness about pancreatic cancer, a disease with a notably low five-year survival rate of just 7%. By designating November 2026 as Pancreatic Cancer Awareness Month, the resolution aims to encourage early detection and support for patients and their families. ([legiscan.com](https://legiscan.com/CA/text/SR122/id/3455205?utm_source=openai))
While SR122 serves to raise awareness about pancreatic cancer, some may view it as a symbolic gesture without direct impact on funding or research initiatives. Critics might argue that more substantial legislative actions are needed to address the challenges posed by pancreatic cancer.
Source: LegiScan roll call vote data.
About This Analysis
This summary was generated using AI from the bill's official text and metadata. Data sourced from LegiScan and the California State Legislature. Conflict-of-interest analysis for this bill is coming soon.
CA SR122